Login/Sign Up
₹9240*
MRP ₹10500
12% off
₹9240*
MRP ₹10500
12% CB
₹1260 cashback(12%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Paclirock 260Mg/43.4Ml Inj is used to treat various types of cancers, including ovarian and breast cancer (in advanced/spreading state or after surgery) and advanced-stage non-small cell lung cancer. It contains ‘Paclitaxel’, which stops cell division and prevents certain cancer cell growth. Sometimes, Paclirock 260Mg/43.4Ml Inj may cause common side effects, such as nausea, vomiting, mild diarrhoea, and joint or muscle pain. It is not recommended for children below 18 years.
Provide Delivery Location
Available Offers
Whats That
About Paclirock 260Mg/43.4Ml Inj
Paclirock 260Mg/43.4Ml Inj belongs to the group of anti-cancer medicines called anti-microtubule agents used to treat various types of cancers, including ovarian and breast cancer (in advanced/spreading state or after surgery) and advanced-stage non-small cell lung cancer.
Paclirock 260Mg/43.4Ml Inj contains ‘Paclitaxel’, which works by stopping cell division and preventing the growth of certain cancer cells.
In some cases, Paclirock 260Mg/43.4Ml Inj may cause common side effects, such as nausea, vomiting, mild diarrhoea, and joint or muscle pain. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.
Consult your doctor if you are pregnant, breastfeeding, think you may be pregnant or are planning pregnancy. Paclirock 260Mg/43.4Ml Inj is not recommended for children below 18 years. Inform your doctor about your health condition and medications to rule out any side effects.
Uses of Paclirock 260Mg/43.4Ml Inj
Directions for Use
Medicinal Benefits
Paclirock 260Mg/43.4Ml Inj belongs to the group of anti-cancer medicines called anti-microtubule agents used to treat various types of cancers, including ovarian and breast cancer (in advanced/spreading state or after surgery) and advanced-stage non-small cell lung cancer. It may also be used when other treatments have failed or in combination with other treatments. Paclirock 260Mg/43.4Ml Inj may also be indicated in patients with Kaposi’s sarcoma (cancer that develops from the cells that line lymph or blood vessels) associated with AIDS (Acquired Immuno-Deficiency Syndrome), where other treatments have not been effective. Paclirock 260Mg/43.4Ml Inj contains ‘Paclitaxel’, which works by preventing the growth of certain cancer cells.
How Paclirock 260Mg/43.4Ml Inj Works
Storage
Side Effects of Paclirock 260Mg/43.4Ml Inj
What if I have taken an overdose of Paclirock 260Mg/43.4Ml Inj
Drug Warnings
Do not take Paclirock 260Mg/43.4Ml Inj if you are allergic to any of its components, if your white blood cell or platelet count is very low, if you have a serious uncontrolled infection, and Paclirock 260Mg/43.4Ml Inj has to be given for the treatment of Kaposi’s sarcoma (cancer that causes lesions in soft tissues), or if you have severe liver problems. Inform your doctor if you have heart disease, abnormal blood cell counts, irregular heartbeat, tingling, numbness, or burning sensation in fingers or toes, visual problems, if you are on radiation therapy, or if you have Kaposi’s sarcoma and have a sore or inflamed mouth. Also, inform your doctor if you are pregnant, breastfeeding, think you are pregnant or planning pregnancy.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
by Others
by Others
by Others
by AYUR
by Others
Product Substitutes
Alcohol
Consult your doctor
It is not known if alcohol interacts with this medicine. Please consult your doctor.
Pregnancy
Unsafe
Paclirock 260Mg/43.4Ml Inj must not be given during pregnancy unless clearly necessary, as it may cause birth defects. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Paclirock 260Mg/43.4Ml Inj.
Breast Feeding
Unsafe
Avoid breastfeeding whilst on treatment with Paclirock 260Mg/43.4Ml Inj. Do not restart breastfeeding until your doctor tells you it is safe to do so.
Driving
Caution
Paclirock 260Mg/43.4Ml Inj may cause dizziness, tiredness, or nausea. Drive or operate heavy machinery only if you are alert.
Liver
Caution
Do not use Paclirock 260Mg/43.4Ml Inj if you have severe liver problems. If you have a history of liver disease, inform your doctor before receiving Paclirock 260Mg/43.4Ml Inj.
Kidney
Consult your doctor
If you have a history of kidney diseases, inform your doctor before receiving Paclirock 260Mg/43.4Ml Inj. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Children
Unsafe
Paclirock 260Mg/43.4Ml Inj is not recommended for children below 18 years due to a lack of data on the safety and effectiveness.
Paclirock 260Mg/43.4Ml Inj is used to treat Ovarian cancer, breast cancer, non-small cell lung cancer.
Paclirock 260Mg/43.4Ml Inj works by stopping cell division and preventing the growth of certain cancer cells.
Paclirock 260Mg/43.4Ml Inj might cause sterility which could be permanent. Please talk to your doctor if you have any concerns.
The most common side effect of Paclirock 260Mg/43.4Ml Inj is hair loss. The hair may grow back after the treatment with Paclirock 260Mg/43.4Ml Inj is finished. However, consult your doctor if you have any concerns.
Yes, Paclirock 260Mg/43.4Ml Inj is cytotoxic. It works by interfering with the growth of cancer cells, preventing them from dividing and causing them to die. However, its cytotoxic nature also means it can affect normal, healthy cells, potentially leading to side effects.
Yes, Paclirock 260Mg/43.4Ml Inj is considered a vesicant. A vesicant is a chemical substance that, if it leaks out of the vein (extravasation), can cause blistering of the skin and surrounding tissues. If Paclirock 260Mg/43.4Ml Inj accidentally leaks during intravenous (IV) infusion, it may lead to inflammation, blistering, or even tissue necrosis. Your healthcare provider will take precautions to ensure the drug is infused properly and monitor the infusion site for any signs of leakage. If extravasation occurs, the infusion should be stopped immediately, and steps should be taken to minimize the damage.
Paclirock 260Mg/43.4Ml Inj is an effective cancer treatment with a low risk of cardiac side effects. Your healthcare team will closely monitor your heart function to ensure your safety. They'll watch for any changes in heart rhythms or blood pressure, and work with you to manage any potential issues. With careful monitoring, you can receive this life-saving treatment with confidence.
Paclirock 260Mg/43.4Ml Inj is a natural product derived from the bark of the Pacific yew tree (Taxus baccata). It is a chemotherapy medication used to treat various cancers, including breast, ovarian, and lung cancer.
The common side effects of Paclirock 260Mg/43.4Ml Inj include nausea, vomiting, mild diarrhoea, and joint or muscle pain. Not everyone will experience all of these side effects, and they typically resolve once the treatment is stopped. However, if the side effects persist or worsen, please consult your doctor.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.
We provide you with authentic, trustworthy and relevant information